Pharmaceuticals
3 articles
Dr. Reddy's Shares Plunge 7% on Semaglutide Supply Delay Over Quality Issue
Dr. Reddy's Laboratories saw its shares drop sharply after delaying commercial supplies of its semaglutide product due to a critical API quality issu…
Shares of Dr. Reddy's Laboratories experienced a significant downturn on Thursday, falling by as much as 6.5% on the BSE. The sharp decline came after the pharmaceutical giant announced a d…Shares of Dr. Reddy's Laboratories experienced a significant downturn on Thursday, falling by as much as 6.5% on the BSE. The sharp decline came after the pharmaceutical giant announced a delay in the commercial supplies of its crucial semaglutide product, citing a quality-related issue concerning ... Read full article.
Wockhardt Shares Hit 13-Year High as New Life-Saving Antibiotic Gets Nod!
Wockhardt stocks skyrocket to record highs after India approves Zaynich, a breakthrough antibiotic for superbugs. See how this game-changer is shakin…
Wockhardt shares have absolutely surged on the stock market today, reaching a record high of Rs 1,975.50. This isn't just a minor bump; it’s a massive breakout rally that investors have bee…Wockhardt shares have absolutely surged on the stock market today, reaching a record high of Rs 1,975.50. This isn't just a minor bump; it’s a massive breakout rally that investors have been waiting for for over 13 years. The company’s market capitalization has now soared to over Rs 31,000 crore, ... Read full article.
Eli Lilly's New Weight Loss Drug Hits Massive 30% Weight Loss Milestone
Phase 3 trial results for Lilly's retatrutide show staggering weight loss results that could rival surgery. Here is what this breakthrough means for …
Eli Lilly and Company has just dropped some major news that could change the landscape of weight loss forever. Their experimental drug, retatrutide, has shown incredible results in Phase 3 …Eli Lilly and Company has just dropped some major news that could change the landscape of weight loss forever. Their experimental drug, retatrutide, has shown incredible results in Phase 3 trials, with some patients losing up to 30% of their total body weight over a two-year period. This new triple ... Read full article.